DARPA funds ExThera Medical’s ‘Seraph’ Blood Filter for Pre-Clinical Testing

ExThera Medical Announces Updates on Seraph™ Development Program to be Presented at the 2016 Military Health System Research Summit (MHSRS)

ExThera Medical Closes Financing Led by Fresenius Medical Care Ventures to Support Commercialization of Innovative Technology to Remove Pathogens from Whole Blood

ExThera Medical Achieves Promising Preliminary Safety and Efficacy Results in a Large-Animal Model

ExThera Medical Announces Initiation of Clinical Trials of its Seraph® Microbind® Affinity Blood Filter (Seraph)

ExThera Medical Presents Results of Cytomegalovirus (CMV) Binding Study

ExThera Medical Joins Battelle Team to Work on DARPA’s DLT Program, Aimed at Developing a Medical Device for Treating Sepsis

ExThera Medical Publishes Results of ‘CRE Superbug’ Binding Study: A Device-based Therapy for Drug-resistant Bacterial Infections Is Now Possible